Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of securities of Jayud Global Logistics Ltd. for the period between April 21, 2023, and April 30, 2025, due to alleged fraudulent activities and misleading statements by the company [1][5]. Group 1: Lawsuit Details - The class action lawsuit claims that Jayud was involved in a fraudulent stock promotion scheme that included misinformation on social media and impersonation of financial professionals [5]. - Allegations include that insiders used offshore accounts to dump shares during a price inflation campaign, and that Jayud's public statements failed to disclose the false rumors and artificial trading activity affecting stock prices [5]. - The lawsuit asserts that the positive statements made by Jayud regarding its business and operations were materially misleading and lacked a reasonable basis [5]. Group 2: Participation Information - Investors who purchased Jayud securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, interested parties can visit the provided link or contact the law firm directly for more information [3][6]. - A lead plaintiff must file a motion with the court by January 20, 2026, to represent other class members in the litigation [1][3]. Group 3: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and consistently ranking among the top firms for securities class action settlements [4]. - The firm has recovered hundreds of millions of dollars for investors, with over $438 million secured in 2019 alone [4].

Accessibility StatementSkip Navigation BENSALEM, Pa., Nov. 21, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Inspire Medical Systems, Inc. ("Inspire" or the "Company") (NYSE: INSP) 21% more press release views with Request a Demo Also from this source IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN INSPIRE MEDICAL SYSTEMS, INC. (INSP), CONTACT THE LAW OFFICES OF HOWARD G. SMIT ...

Core Viewpoint - Freeport-McMoran Inc. is facing a class action lawsuit due to alleged securities fraud related to safety issues at its Grasberg Block Cave operation in Indonesia, which resulted in significant stock price declines following a tragic incident involving trapped workers [2][3][4][5][6]. Incident Overview - On September 9, 2025, Freeport announced the suspension of mining activities at the Grasberg Block Cave after a large flow of wet material trapped seven workers, leading to a stock price drop of $2.77, or 5.9%, closing at $43.89 per share [2]. - An update on September 24, 2025, revealed that two of the trapped workers had died, causing the stock price to fall by $7.69, or 17%, to close at $37.67 per share [3]. - Following media reports on September 25, 2025, regarding the implications of the production halt on Freeport's relationship with the Indonesian government, the stock price dropped another $2.33, or 6.2%, closing at $35.34 [4]. Lawsuit Details - The class action lawsuit alleges that Freeport made materially false and misleading statements and failed to disclose critical safety risks associated with its operations [5][6]. - Specific allegations include inadequate safety measures at the Grasberg mine, which heightened the risk of worker fatalities and led to undisclosed regulatory and reputational risks [6].

Core Viewpoint - Alibaba Group Holding Limited is under investigation for potential violations of federal securities laws following allegations that it assists the Chinese military in targeting the US, which has led to a decline in its stock price [1][2]. Investigation Details - The investigation is initiated by The Law Offices of Frank R. Cruz on behalf of investors who may have suffered losses due to these allegations [1]. - A Financial Times article published on November 14, 2025, claims that a White House memo indicates Alibaba provides the People's Liberation Army (PLA) with capabilities that threaten US security [2]. - The memo alleges that Alibaba grants the Chinese government and PLA access to sensitive customer data, including IP addresses, WiFi information, and payment records, as well as AI-related services [2]. Stock Market Reaction - Following the publication of the allegations, Alibaba's shares experienced a decline of $6.04, or 3.78%, closing at $153.80 per share on November 14, 2025 [2].

Core Viewpoint - A class action securities lawsuit has been filed against Inspire Medical Systems, Inc. due to alleged securities fraud affecting investors between August 6, 2024, and August 4, 2025 [2][3]. Group 1: Lawsuit Details - The lawsuit claims that the launch of Inspire Medical's new product, Inspire V, was unsuccessful due to poor demand and excess inventory at treatment centers, contradicting the company's assurances of a successful launch [3]. - Defendants allegedly failed to complete essential tasks for the product launch, including training for treatment center customers, setting up IT systems, and ensuring proper Medicare reimbursement [3]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until January 5, 2026, to request appointment as lead plaintiff, although participation in any recovery does not require this [4]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [4]. Group 3: Legal Firm Background - Levi & Korsinsky, LLP has a history of securing significant settlements for shareholders and is recognized as one of the top securities litigation firms in the United States [5].

Core Viewpoint - A class action securities lawsuit has been filed against CarMax, Inc. for alleged securities fraud affecting investors between June 20, 2025, and September 24, 2025 [1][2]. Group 1: Lawsuit Details - The complaint alleges that defendants made false statements and concealed information regarding CarMax's growth prospects, claiming that the growth was overstated and resulted from temporary benefits due to customer speculation about tariffs [2]. - The lawsuit seeks to recover losses for investors who were adversely affected by these misleading statements [1]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until January 2, 2026, to request to be appointed as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years and consistently ranking among the top securities litigation firms in the U.S. [4].

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) Avantor's competitive positioning was weaker than defendants had publicly represented; (2) Avantor was experiencing negative effects from increased competition; and (3) as a result, defendants' representations about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis. WHAT'S NEXT? If you suffered a loss in Avantor, Inc. during the rele ...

Core Viewpoint - Molina Healthcare, Inc. is facing a class action securities lawsuit due to alleged securities fraud that occurred between February 5, 2025, and July 23, 2025, which has adversely affected investors [1][2]. Group 1: Allegations and Impact - The lawsuit claims that the defendants made false statements and concealed material adverse facts regarding the company's medical cost trend assumptions [2]. - It is alleged that Molina was experiencing a dislocation between premium rates and medical cost trends, which could lead to a significant cut in the company's financial guidance for fiscal year 2025 [2]. - The lawsuit suggests that Molina's near-term growth was reliant on a lack of utilization of behavioral health, pharmacy, and inpatient and outpatient services, which misled investors about the company's business prospects [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until December 2, 2025, to request to be appointed as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, indicating a no-cost participation in the lawsuit [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years and consistently ranking among the top securities litigation firms in the United States [4].

Core Viewpoint - A class action securities lawsuit has been filed against Freeport-McMoRan Inc. alleging securities fraud affecting investors between February 15, 2022, and September 24, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Freeport-McMoRan did not ensure adequate safety at the Grasberg Block Cave mine in Indonesia, which posed a heightened risk of worker fatalities [3]. - It is alleged that the lack of safety measures led to undisclosed regulatory, litigation, and reputational risks, making the company's statements about its business and operations materially false and misleading [3]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until January 12, 2026, to request appointment as lead plaintiff, although participation does not require serving in this role [4]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [4]. Group 3: Legal Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [5].

Core Viewpoint - aTyr Pharma, Inc. is facing a class action securities lawsuit due to alleged securities fraud related to misleading statements about the efficacy of its drug Efzofitimod, which led to significant stock price decline after the truth was revealed [1][2]. Group 1: Lawsuit Details - The lawsuit seeks to recover losses for aTyr investors affected by alleged securities fraud between November 7, 2024, and September 12, 2025 [1]. - Defendants allegedly provided positive statements while concealing adverse facts about Efzofitimod's efficacy, particularly its ability to allow patients to taper steroid usage [2]. - The truth emerged on September 15, 2025, when aTyr announced that the EFZO-FIT study did not meet its primary endpoint, leading to a drastic stock price drop from $6.03 to $1.02, a decline of 83.2% in one day [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the relevant timeframe have until December 8, 2025, to request to be appointed as lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions for shareholders over the past 20 years [4]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the U.S. [4].